NCT05929664View on ClinicalTrials.gov

Cemiplimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

PHASE2RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

July 5, 2027

Study Completion Date

July 5, 2027

Conditions
Locally Advanced Basal Cell Carcinoma
Interventions
BIOLOGICAL

Cemiplimab

Given IV

PROCEDURE

Computed Tomography

Undergo CT scan

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

OTHER

Quality-of-Life Assessment

Ancillary studies

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Biopsy

Undergo biopsy

Trial Locations (3)

19107

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

33136

RECRUITING

University of Miami Health System, Miami

37232

RECRUITING

Vanderbilt University, Nashville

All Listed Sponsors
lead

Thomas Jefferson University

OTHER